Correlation Between HCW Biologics and NeuroSense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on HCW Biologics and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and NeuroSense Therapeutics.

Diversification Opportunities for HCW Biologics and NeuroSense Therapeutics

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between HCW and NeuroSense is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and NeuroSense Therapeutics go up and down completely randomly.

Pair Corralation between HCW Biologics and NeuroSense Therapeutics

Given the investment horizon of 90 days HCW Biologics is expected to generate 2.51 times more return on investment than NeuroSense Therapeutics. However, HCW Biologics is 2.51 times more volatile than NeuroSense Therapeutics Ltd. It trades about 0.14 of its potential returns per unit of risk. NeuroSense Therapeutics Ltd is currently generating about 0.13 per unit of risk. If you would invest  45.00  in HCW Biologics on August 29, 2024 and sell it today you would earn a total of  11.00  from holding HCW Biologics or generate 24.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy68.18%
ValuesDaily Returns

HCW Biologics  vs.  NeuroSense Therapeutics Ltd

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
NeuroSense Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

HCW Biologics and NeuroSense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and NeuroSense Therapeutics

The main advantage of trading using opposite HCW Biologics and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.
The idea behind HCW Biologics and NeuroSense Therapeutics Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities